BTAI
Price
$0.36
Change
-$0.03 (-7.69%)
Updated
Dec 18, 04:59 PM (EDT)
78 days until earnings call
LEXX
Price
$2.11
Change
+$0.03 (+1.44%)
Updated
Dec 18, 04:59 PM (EDT)
28 days until earnings call
Ad is loading...

BTAI vs LEXX

Header iconBTAI vs LEXX Comparison
Open Charts BTAI vs LEXXBanner chart's image
BioXcel Therapeutics
Price$0.36
Change-$0.03 (-7.69%)
Volume$946
CapitalizationN/A
Lexaria Bioscience
Price$2.11
Change+$0.03 (+1.44%)
Volume$3.61K
CapitalizationN/A
BTAI vs LEXX Comparison Chart
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. LEXX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and LEXX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BTAI: $0.39 vs. LEXX: $2.08)
Brand notoriety: BTAI and LEXX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 84% vs. LEXX: 210%
Market capitalization -- BTAI: $18.86M vs. LEXX: $36.3M
BTAI [@Biotechnology] is valued at $18.86M. LEXX’s [@Biotechnology] market capitalization is $36.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileLEXX’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • LEXX’s FA Score: 0 green, 5 red.
According to our system of comparison, LEXX is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 5 TA indicator(s) are bullish while LEXX’s TA Score has 2 bullish TA indicator(s).

  • BTAI’s TA Score: 5 bullish, 5 bearish.
  • LEXX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, BTAI is a better buy in the short-term than LEXX.

Price Growth

BTAI (@Biotechnology) experienced а -11.22% price change this week, while LEXX (@Biotechnology) price change was -16.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

BTAI is expected to report earnings on Mar 06, 2025.

LEXX is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEXX($36.3M) has a higher market cap than BTAI($17.2M). LEXX YTD gains are higher at: 66.400 vs. BTAI (-86.776). LEXX has higher annual earnings (EBITDA): -4.51M vs. BTAI (-56.15M). BTAI has more cash in the bank: 40.4M vs. LEXX (8.51M). LEXX has less debt than BTAI: LEXX (143K) vs BTAI (105M). BTAI has higher revenues than LEXX: BTAI (2.28M) vs LEXX (411K).
BTAILEXXBTAI / LEXX
Capitalization17.2M36.3M47%
EBITDA-56.15M-4.51M1,245%
Gain YTD-86.77666.400-131%
P/E RatioN/AN/A-
Revenue2.28M411K554%
Total Cash40.4M8.51M475%
Total Debt105M143K73,427%
FUNDAMENTALS RATINGS
BTAI vs LEXX: Fundamental Ratings
BTAI
LEXX
OUTLOOK RATING
1..100
534
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9557
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LEXX's Valuation (57) in the null industry is in the same range as BTAI (82) in the Biotechnology industry. This means that LEXX’s stock grew similarly to BTAI’s over the last 12 months.

LEXX's Profit vs Risk Rating (100) in the null industry is in the same range as BTAI (100) in the Biotechnology industry. This means that LEXX’s stock grew similarly to BTAI’s over the last 12 months.

LEXX's SMR Rating (98) in the null industry is in the same range as BTAI (100) in the Biotechnology industry. This means that LEXX’s stock grew similarly to BTAI’s over the last 12 months.

LEXX's Price Growth Rating (57) in the null industry is somewhat better than the same rating for BTAI (95) in the Biotechnology industry. This means that LEXX’s stock grew somewhat faster than BTAI’s over the last 12 months.

LEXX's P/E Growth Rating (100) in the null industry is in the same range as BTAI (100) in the Biotechnology industry. This means that LEXX’s stock grew similarly to BTAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAILEXX
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 9 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ERIE424.341.10
+0.26%
Erie Indemnity Company
ONIT33.70-0.30
-0.88%
Onity Group Inc.
XELB0.53-0.01
-2.16%
Xcel Brands
HI30.81-0.69
-2.19%
Hillenbrand
HCSG11.80-0.57
-4.61%
Healthcare Services Group

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with ORMP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
-4.01%
ORMP - BTAI
44%
Loosely correlated
-1.67%
SYBX - BTAI
42%
Loosely correlated
-2.36%
AXON - BTAI
42%
Loosely correlated
-2.09%
INO - BTAI
39%
Loosely correlated
-8.84%
IGMS - BTAI
38%
Loosely correlated
+1.08%
More

LEXX and

Correlation & Price change

A.I.dvisor tells us that LEXX and MIST have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
-3.70%
MIST - LEXX
28%
Poorly correlated
+1.68%
RGNX - LEXX
27%
Poorly correlated
-0.82%
BTAI - LEXX
27%
Poorly correlated
-4.01%
VXRT - LEXX
27%
Poorly correlated
+0.99%
MRSN - LEXX
26%
Poorly correlated
-1.93%
More